INCYTE CORPORATION Restricted Cash and Investments, Current
INCYTE CORPORATION (INCY) had Restricted Cash and Investments, Current of $16.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Restricted Cash and Investments, Current
us-gaap:RestrictedCashAndInvestmentsCurrent · last filed 2017-02-14
- 2016-12-31: Restricted Cash and Investments, Current $16.00K.
- 2016-09-30: Restricted Cash and Investments, Current $17.00K.
- 2016-06-30: Restricted Cash and Investments, Current $16.00K.
- 2016-03-31: Restricted Cash and Investments, Current $517.00K.
| Period end | Restricted Cash and Investments, Current |
|---|---|
| 2016-12-31 | $16.00K 10-K · filed 2017-02-14 |
| 2016-09-30 | $17.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $16.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $517.00K 10-Q · filed 2016-05-09 |
| 2015-12-31 | $516.00K 10-K · filed 2017-02-14 |
| 2015-09-30 | $517.00K 10-Q · filed 2015-11-03 |
| 2015-06-30 | $517.00K 10-Q · filed 2015-08-04 |
| 2015-03-31 | $500.00K 10-Q · filed 2015-04-30 |
| 2014-12-31 | $500.00K 10-K · filed 2016-02-12 |
| 2014-09-30 | $500.00K 10-Q · filed 2014-10-30 |
| 2014-06-30 | $750.00K 10-Q · filed 2014-07-31 |
| 2014-03-31 | $625.00K 10-Q · filed 2014-05-01 |
| 2013-12-31 | $500.00K 10-K · filed 2015-02-17 |
| 2012-09-30 | $9.50M 10-Q · filed 2012-11-01 |
| 2011-12-31 | $19.29M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |